Mayoly
Mayoly is a French, family-owned pharmaceutical laboratory with over 100 years of heritage, operating across gastroenterology, dermocosmetics (Topicrem), probiotics (Probiolog), and Helicobacter pylori diagnostics (Kibion, Mayoly Diagnostic), serving patients, healthcare professionals, and consumers in 100+ countries.
- Company typePrivate
- Founded1912
- HeadquartersRueil-Malmaison, Île-de-France, France
- Headcount1,001–5,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Mayoly does
Mayoly is a French, family-owned and independent pharmaceutical laboratory headquartered in Rueil-Malmaison, Île-de-France, operating for more than 100 years across five segments: Consumer Healthcare (notably Probiolog probiotics and OTC products), Pharma (Mayoly-Spindler brand spanning gastroenterology, ORL, and rheumatology), Dermocosmetics (Topicrem brand for sensitive skin of babies, children, and adults), Diagnostic (Mayoly Diagnostic and Kibion systems for Helicobacter pylori testing), and Production (contract and captive manufacturing). The company serves a multi-tier customer base that includes end consumers and patients buying through pharmacies, healthcare professionals such as pharmacists, dermatologists, and gastroenterologists who recommend or prescribe its products, medical laboratories using its diagnostic platforms, and B2B partners requiring GMP-compliant manufacturing capacity.
Its core technology combines pharmaceutical manufacturing at six industrial sites (five in France - three in the Paris region, one in Dreux, one in L'Isle-sur-la-Sorgue - and one international), dermo-cosmetic formulation expertise built around the Topicrem range created in 1994, and proprietary diagnostic instrumentation for H. pylori detection and eradication control acquired through the 2016 Kibion acquisition and formalized as Mayoly Diagnostic in 2019. More than 85% of products sold worldwide are manufactured at its French sites, and nearly 100% of the Topicrem range is produced in-house.
Mayoly monetizes primarily through one-time sales of prescription and OTC pharmaceuticals, dermo-cosmetic products, and probiotic food supplements via pharmacy distribution channels in more than 100 countries, supplemented by diagnostic system and consumable sales and contract manufacturing services. Go-to-market is sales-led, anchored by pharmaceutical sales representatives (délégués pharmaceutiques) engaging pharmacies and healthcare professionals, with parallel international distribution through local subsidiaries and partner networks and a growing digital and pharmacy e-commerce presence for Topicrem.
Mayoly firmographics
Firmographics- Name
- Mayoly
- Legal name
- MAYOLY
- Website
- https://mayoly.com
- Company type
- Private
- Founded year
- 1912
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Mayoly is a French, family-owned pharmaceutical laboratory with over 100 years of heritage, operating across gastroenterology, dermocosmetics (Topicrem), probiotics (Probiolog), and Helicobacter pylori diagnostics (Kibion, Mayoly Diagnostic), serving patients, healthcare professionals, and consumers in 100+ countries.
- Ownership category
- akta.pro rank
Mayoly industry classification
Industry- Product category
- Pharmaceutical and Dermo-Cosmetic Products
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Soap and Cleaning Compound Manufacturing (32561), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844), Services-Medical Laboratories (8071), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)
- akta.pro secondary industries
- Probiotics & Digestive Health Supplements (CRADAGAF), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
Keywords
Where Mayoly is headquartered
LocationHeadquarters
- HQ city
- Rueil-Malmaison, Île-de-France
- HQ country
- France
- HQ region
- Europe
Offices6 records
Markets served
Mayoly business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical products: Core pharmaceutical business focused on gastroenterology, ORL, and rheumatology with production from French industrial sites in Chatou and Dammarie-les-Lys
- Consumer Healthcare - OTC and supplements: Over-the-counter medications and supplements including Probiolog (probiotics) and other consumer health products sold in pharmacies
- Dermocosmetics - Topicrem brand: Dermo-cosmetic products under Topicrem brand for sensitive skin, present in more than 40 countries
- Pharma - Mayoly-Spindler: General medicine products with expertise in ORL, rheumatology, and gastroenterology
- Diagnostic - Mayoly Diagnostic: Diagnostic systems and consumables for Helicobacter pylori testing and eradication control
- Contract manufacturing: Industrial production services with 5.3M EUR investment in 2022 for maintenance and decarbonation
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Mayoly product offering
Product offeringCore offering
Mayoly is a French, family-owned pharmaceutical laboratory that develops, manufactures, and commercializes pharmaceutical products focused on gastroenterology, ORL, and rheumatology, along with dermo-cosmetic skincare products (Topicrem) for sensitive skin, probiotic supplements (Probiolog), and H. pylori diagnostic systems (Mayoly Diagnostic/Kibion). The company operates 6 industrial sites that manufacture more than 85% of its products and distributes through pharmacy networks in 100+ countries.
Product overview
Mayoly is a French, family-owned, independent pharmaceutical laboratory with over 100 years of expertise. The company operates across four main segments: Pharma (centered on gastroenterology, ORL, and rheumatology), Dermocosmetics (via the Topicrem brand), Diagnostic (via Mayoly Diagnostic and Kibion), and Production (manufacturing with 6 industrial sites). The portfolio includes prescription and OTC pharmaceuticals, dermo-cosmetic skincare products, probiotic supplements (Probiolog), and diagnostic solutions for Helicobacter pylori. The company employs over 2,200 collaborators across more than 100 countries.
Differentiator
Problem solved
Functional benefit
Brands
- Topicrem: Dermo-cosmetic brand created by Jean-Gilles Vernin in 1994 for sensitive skin care products for babies, children and adults. Present in more than 40 countries.
- Kibion
- Mayoly Diagnostic
- Mayoly-Spindler
- Probiolog
Quantifiable outcome
- 41% reduction in scopes 1 and 2 emissions achieved in 2025 vs 2019 baseline, on track for 50% reduction by 2030
- +2 more outcomes
Companies that use Mayoly
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Mayoly technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Mayoly partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor and core.
- Pierre-Louis Attwell (IMOCA RESILIENT)minorMayoly has partnered with skipper Pierre-Louis Attwell and his IMOCA RESILIENT sailing vessel for the Vendée Globe 2028 race. This partnership, starting from 2016, embodies shared values of entrepreneurship, ambition, authenticity and challenge. The partnership represents Mayoly's commitment to pushing boundaries and transforming challenges into opportunities.
- KibioncoreMayoly acquired Kibion in 2016, an international player in functional exploration instruments and tests for Helicobacter pylori diagnosis and eradication control. This acquisition enabled Mayoly to create Mayoly Diagnostic in 2019 as a strategic pillar for the development of the laboratories.
Scale indicators8 records
Recent moves7 records
Expansion highlights5 records
Mayoly competitors and assessment
Company assessmentDirect peers
- Galderma: Global dermatology-focused pharmaceutical and dermo-cosmetic company; directly comparable to Mayoly's Topicrem franchise in sensitive-skin prescription and OTC dermatology, with a larger but adjacent therapeutic-area focus.
- HRA Pharma: Mid-sized European specialty pharmaceutical company with a mix of Rx, OTC, and consumer healthcare brands focused on a small number of therapeutic areas; similar scale, specialty-pharma profile, and prior M&A activity (e.g., Perrigo acquisition) make HRA Pharma a comparable peer.
- BioGaia: Swedish probiotic and digestive-health specialist selling through pharmacy and HCP channels globally; directly comparable to Mayoly's Probiolog consumer healthcare probiotics franchise in terms of brand positioning, channel, and category.
- Uriage (Laboratoires Dermatologiques d'Uriage): French dermo-cosmetics specialist sold through pharmacy channels globally; highly comparable to Topicrem in pharmacy-distributed sensitive-skin skincare positioning, channel strategy, and brand-portfolio structure.
- Pierre Fabre: French family-owned pharmaceutical and dermo-cosmetics group with overlapping activities in dermatology, gastroenterology-adjacent pharma, and in-house manufacturing; comparable scale, ownership structure, and brand-led dermo positioning make it the closest like-for-like peer to Mayoly.
- Cooper Consumer Health (formerly Omega Pharma): European mid-size consumer healthcare platform with broad OTC portfolio distributed primarily via pharmacy and drugstore channels; comparable in mid-size European OTC/consumer healthcare positioning, channel structure, and recent PE-backed strategic profile.
Broad incumbents
- Bayer Consumer Health: Broad incumbent in OTC and consumer healthcare with significant pharmacy distribution and international footprint; directly competes with Mayoly's consumer healthcare and probiotic supplements portfolio, though from a much larger and more diversified base.
- Sanofi: Large French multinational pharmaceutical company with overlapping franchises in gastroenterology, consumer healthcare (OTC, probiotics), and dermatology; competes for the same HCP and pharmacy channel relationships but at materially greater scale and breadth.
- Servier: Privately held French pharmaceutical laboratory with a broader therapeutic-area portfolio and significant international footprint; comparable French private-pharma heritage, governance style, and scale put it in the same peer set even though its portfolio is wider than Mayoly's gastroenterology/dermatology focus.
Emerging players
- La Roche-Posay (L'Oréal Dermatological Beauty): L'Oréal-owned dermatological skincare brand distributed primarily through pharmacy channels globally; competes head-to-head with Topicrem in sensitive-skin skincare but operates as a brand within a much larger cosmetics platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Mayoly social profiles
Digital presenceMayoly financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mayoly leadership team
Management profileNumber of profiles
Profiles2 records
Mayoly subsidiaries and ownership
Company hierarchySubsidiaries4 records
Mayoly funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mayoly M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mayoly
What does Mayoly do?
Mayoly is a French, family-owned pharmaceutical laboratory that develops, manufactures, and commercializes pharmaceutical products focused on gastroenterology, ORL, and rheumatology, along with dermo-cosmetic skincare products (Topicrem) for sensitive skin, probiotic supplements (Probiolog), and H. pylori diagnostic systems (Mayoly Diagnostic/Kibion). The company operates 6 industrial sites that manufacture more than 85% of its products and distributes through pharmacy networks in 100+ countries.
Is Mayoly a public or private company?
Mayoly is a private company. It is classified as family owned and is currently operating.
When was Mayoly founded?
Mayoly was founded in 1912. It employs 1,001 to 5,000 people.
Where is Mayoly based?
Mayoly is headquartered in Rueil-Malmaison, Île-de-France, France, in the Europe region.
How does Mayoly make money?
Six revenue lines are on record. Pharmaceutical products are the primary driver. The others are consumer Healthcare - OTC and supplements, dermocosmetics - Topicrem brand, pharma - Mayoly-Spindler, diagnostic - Mayoly Diagnostic and contract manufacturing.
Who are Mayoly's main competitors?
Direct peers on record are Galderma, HRA Pharma, BioGaia, Uriage (Laboratoires Dermatologiques d'Uriage), Pierre Fabre and Cooper Consumer Health (formerly Omega Pharma). Broad incumbents are Bayer Consumer Health, Sanofi and Servier. La Roche-Posay (L'Oréal Dermatological Beauty) is listed as an emerging player.
Does Mayoly have an API?
No public API is recorded for Mayoly.
What industry is Mayoly in?
Mayoly's product category is Pharmaceutical and Dermo-Cosmetic Products. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 325412 and its SIC code is 2834.